SCHEMBL23057166

SCHEMBL23057166

CN(C)S(=O)(=O)c1ccc(S(=O)(=O)Nc2ccccc2N2CCC(O)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCOLN3 Q8TDD5 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
PKM P14618 1/20 0.52
MCOLN2 Q8IZK6 2/20 0.51
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50
HPGD P15428 1/20 0.50
MCOLN1 Q9GZU1 1/20 0.50
GAA P10253 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TSHR P16473 2/20 0.45
HTT P42858 2/20 0.45
GFER P55789 1/20 0.43
KMT2A Q03164 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
CSF1R P07333 1/20 0.41
RORC P51449 1/20 0.41
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23379508 0.89 MCOLN3 (0.56) MCOLN3L3MBTL1PKMMCOLN2ALDH1A1
SCHEMBL23057145 0.89 L3MBTL1 (0.53) MCOLN3L3MBTL1PKMMCOLN2ALDH1A1
SCHEMBL29979001 0.88 MCOLN2 (0.47) MCOLN3L3MBTL1PKMMCOLN2ALDH1A1
SCHEMBL23043612 0.88 ALDH1A1 (0.52) MCOLN3L3MBTL1PKMMCOLN2ALDH1A1
SCHEMBL23043701 0.88 L3MBTL1 (0.49) MCOLN3L3MBTL1PKMMCOLN2ALDH1A1
SCHEMBL23043625 0.87 ALDH1A1 (0.52) MCOLN3L3MBTL1PKMMCOLN2ALDH1A1
SCHEMBL23057180 0.87 MCOLN3 (0.68) MCOLN3L3MBTL1PKMMCOLN2ALDH1A1
SCHEMBL23355024 0.86 MCOLN3 (0.54) MCOLN3L3MBTL1PKMMCOLN2ALDH1A1
SCHEMBL23044597 0.86 MCOLN3 (0.51) MCOLN3L3MBTL1PKMMCOLN2ALDH1A1
SCHEMBL23057085 0.85 MCOLN3 (0.70) MCOLN3L3MBTL1PKMMCOLN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230010299-A1 HETEROCYCLIC TRPML1 AGONISTS LIBRA THERAPEUTICS, INC. 2023-01-12 US disclosed
WO-2021094974-A1 HETEROCYCLIC TRPML1 AGONISTS LIBRA THERAPEUTICS, INC. (US) 2021-05-20 WO disclosed
WO-2021041866-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2021-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230010299-A1 HETEROCYCLIC TRPML1 AGONISTS TRPM7, TRPM2, TRPM5 MCOLN3 12/4885L3MBTL1 3739/4885PKM 1880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.